{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:15:23Z","timestamp":1788538523957,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jmgm.2026.109539","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T06:04:07Z","timestamp":1785996247000},"page":"109539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structure-based elucidation of thiazine inhibitors targeting estrogen receptors alpha: pharmacophore modeling, virtual screening, molecular docking, MD, and DFT approach"],"prefix":"10.1016","volume":"148","author":[{"given":"M.S.","family":"Sanjeev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhim","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailash","family":"Jangid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-5251","authenticated-orcid":false,"given":"Vikas","family":"Jaitak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2026.109539_bib1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of cancer","volume":"21","author":"Brown","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jmgm.2026.109539_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1622954","article-title":"Global burden and projections of breast cancer incidence and mortality to 2050: a comprehensive analysis of GLOBOCAN data","volume":"13","author":"Freihat","year":"2025","journal-title":"Front. Public Health"},{"key":"10.1016\/j.jmgm.2026.109539_bib3","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer\u2014epidemiology, risk factors, classification, prognostic markers, and current treatment strategies\u2014an updated review","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jmgm.2026.109539_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/br.2013.187","article-title":"Estrogen receptor-positive breast cancer molecular signatures and therapeutic potentials","volume":"2","author":"Zhang","year":"2014","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.jmgm.2026.109539_bib5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s12094-017-1800-5","article-title":"Biomarkers in breast cancer: a consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology","volume":"20","author":"Colomer","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.jmgm.2026.109539_bib6","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.3390\/ijms24076834","article-title":"A basic review on estrogen receptor signaling pathways in breast cancer","volume":"24","author":"Clusan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109539_bib7","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1007\/s00018-021-03860-4","article-title":"Estrogen receptor-\u03b1 signaling in post-natal mammary development and breast cancers","volume":"78","author":"Rusidz\u00e9","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jmgm.2026.109539_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast cancer","volume":"37","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jmgm.2026.109539_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.37349\/etat.2021.00052","article-title":"Role of estrogen receptor coregulators in endocrine resistant breast cancer","volume":"2","author":"Altwegg","year":"2021","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.jmgm.2026.109539_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.986016","article-title":"Review of in silico studies dedicated to the nuclear receptor family: therapeutic prospects and toxicological concerns","volume":"13","author":"Sellami","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jmgm.2026.109539_bib11","article-title":"Targeting estrogen receptor alpha in breast cancer for novel therapies resistance mechanisms and future directions","volume":"17","author":"Wu","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.jmgm.2026.109539_bib12","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery","volume":"38","author":"Macalino","year":"2015","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.jmgm.2026.109539_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115518","article-title":"Assessing the potential contribution of in silico studies in discovering drug candidates that interact with various SARS-CoV-2 receptors","volume":"24","author":"Mushebenge","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109539_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/2212796812666180416145232","article-title":"In silico screening and molecular interaction studies of tetrahydrocannabinol and its derivatives with acetylcholine binding protein","volume":"12","author":"Panigrahi","year":"2018","journal-title":"Curr. Chem. Biol."},{"key":"10.1016\/j.jmgm.2026.109539_bib15","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.3390\/ijms21228420","article-title":"Methods and applications of in silico aptamer design and modeling","volume":"21","author":"Buglak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109539_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105149","article-title":"Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-alzheimer\u2019s disease agents","volume":"114","author":"Gao","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2026.109539_bib17","article-title":"Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM\/GBSA, ADME and MD simulation study","volume":"7","author":"Saha","year":"2024","journal-title":"CRSB"},{"key":"10.1016\/j.jmgm.2026.109539_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/157340910790980151","article-title":"Pharmacophore based drug design approach as a practical process in drug discovery","volume":"6","author":"Gao","year":"2010","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.jmgm.2026.109539_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2174\/1573409919666230321145543","article-title":"Synthesis and in-silico studies of 4-phenyl thiazol-2-amine derivatives as putative anti-breast cancer agents","volume":"20","author":"Lavanya","year":"2024","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.jmgm.2026.109539_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Madhavi Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2026.109539_bib21","doi-asserted-by":"crossref","first-page":"10323","DOI":"10.1080\/07391102.2023.2256876","article-title":"Identification of 1, 3, 4-oxadiazoles as tubulin-targeted anticancer agents: a combined field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, molecular dynamics simulation, and density functional theory calculation approach","volume":"42","author":"Das","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109539_bib22","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1080\/07391102.2017.1404931","article-title":"Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease","volume":"36","author":"Patel","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109539_bib23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/08927022.2022.2072840","article-title":"Virtual screening of potential inhibitor against breast cancer-causing estrogen receptor alpha (ER\u03b1): molecular docking and dynamic simulations","volume":"48","author":"Muhammad","year":"2022","journal-title":"Mol. Simul."},{"key":"10.1016\/j.jmgm.2026.109539_bib24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.gene.2019.03.062","article-title":"Molecular docking studies of angiogenesis target protein HIF-1\u03b1 and genistein in breast cancer","volume":"701","author":"Mukund","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.jmgm.2026.109539_bib25","doi-asserted-by":"crossref","first-page":"7627","DOI":"10.1080\/07391102.2022.2123390","article-title":"Flavonoids as P-glycoprotein inhibitors for multidrug resistance in cancer: an in-silico approach","volume":"41","author":"Kumar","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109539_bib26","article-title":"Identification of 1, 5\u2010Benzothiazepine Derivatives as Potent Estrogen Receptor \u03b1 Inhibitors via Integrated De Novo Fragment\u2010Based Designing and Pharmacophore Modeling","volume":"11","author":"Pareek","year":"2026","journal-title":"Chem. Sel"},{"key":"10.1016\/j.jmgm.2026.109539_bib27","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1080\/07391102.2018.1471417","article-title":"Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH)","volume":"37","author":"Saxena","year":"2019","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jmgm.2026.109539_bib28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jmgm.2026.109539_bib29","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1021\/acs.jctc.1c00254","article-title":"Additive CHARMM36 force field for nonstandard amino acids","volume":"17","author":"Croitoru","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2026.109539_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107341","article-title":"Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha","volume":"147","author":"Kaur","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2026.109539_bib31","article-title":"Theoretical assessment of Au32 nanocluster as tiopronin drug agent: DFT calculation and MD simulation; with solvent effect","author":"Alotaibi","year":"2025","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2026.109539_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2025.102105","article-title":"Synthesis and comparative investigations of DFT\/B3LYP, B3PW91, CAM-B3LYP and HSEH1PBE methods applied to molecular structure, spectroscopic analysis, electronic properties of a novel hydrazone having triazole and pyrazole moiety","volume":"14","author":"Lakshminarayana","year":"2025","journal-title":"Results Chem."},{"key":"10.1016\/j.jmgm.2026.109539_bib33","article-title":"In silico approaches for the identification of novel FGFR1 inhibitor in cancer: a fragment-based De novo drug designing guided virtual screening approach","author":"Bala","year":"2025","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2026.109539_bib34","article-title":"Discovery of small\u2010molecules as potential GSK\u20103\u03b2 inhibitors for the treatment of Alzheimer's Disease using pharmacophore\u2010based virtual screening","volume":"9","author":"Jangid","year":"2024","journal-title":"Chem. Sel"},{"key":"10.1016\/j.jmgm.2026.109539_bib35","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1516","article-title":"Toxicity prediction based on artificial intelligence: a multidisciplinary overview","volume":"11","author":"P\u00e9rez Sant\u00edn","year":"2021","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109539_bib36","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2026.109539_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1468","article-title":"Next generation 3D pharmacophore modeling","volume":"10","author":"Schaller","year":"2020","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.jmgm.2026.109539_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107711","article-title":"Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules","volume":"101","author":"Marondedze","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2026.109539_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/minf.201400120","article-title":"Design of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors: virtual screening, synthesis and in vitro biological activities","volume":"34","author":"Devi","year":"2015","journal-title":"Mol. Inf."},{"key":"10.1016\/j.jmgm.2026.109539_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3329\/bjp.v9i2.17543","article-title":"Molecular docking study of active phytocompounds from the methanolic leaf extract of vitex negundo against cyclooxygenase-2","volume":"9","author":"Murugesan","year":"2014","journal-title":"Bangladesh J. Pharmacol."},{"key":"10.1016\/j.jmgm.2026.109539_bib41","article-title":"An in Silico investigation for acyclovir and its derivatives to fight the COVID-19: molecular docking, DFT calculations, ADME and td-Molecular dynamics simulations","volume":"99","author":"Singh","year":"2022","journal-title":"J. Indian Chem. Soc."},{"key":"10.1016\/j.jmgm.2026.109539_bib42","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jmgm.2026.109539_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105686","article-title":"A potential anticancer dihydropyrimidine derivative and its protein binding mechanism by multispectroscopic, molecular docking and molecular dynamic simulation along with its in-silico toxicity and metabolic profile","volume":"158","author":"Wani","year":"2021","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.jmgm.2026.109539_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108427","article-title":"Discovery of natural MCL1 inhibitors using pharmacophore modelling, QSAR, docking, ADMET, molecular dynamics, and DFT analysis","volume":"117","author":"Das","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.jmgm.2026.109539_bib45","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1126\/science.218.4574.747","article-title":"Role of frontier orbitals in chemical reactions","volume":"218","author":"Fukui","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.jmgm.2026.109539_bib46","doi-asserted-by":"crossref","DOI":"10.5935\/1984-6835.20160032","article-title":"New perspectives on the role of frontier molecular orbitals in the study of chemical reactivity: a review","author":"Pereira","year":"2016","journal-title":"Rev. Virtual Quim"}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326002652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326326002652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:32:33Z","timestamp":1788535953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326326002652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":46,"alternative-id":["S1093326326002652"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109539","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based elucidation of thiazine inhibitors targeting estrogen receptors alpha: pharmacophore modeling, virtual screening, molecular docking, MD, and DFT approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2026.109539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109539"}}